Boston Oncology Arabia

Boston Oncology Arabia is a leading pharma and biogenerics company focused on the local manufacturing and commercialization of essential specialty and generic oncology and critical care treatments in Saudi Arabia and the MENA region. The company has established a commercial supply chain and a GMP-certified facility with a capacity exceeding 30 million vials annually, supplying both locally developed and internationally licensed medicines. Its recent partnerships and investor backing have accelerated its expansion into advanced manufacturing and technology localization, with a strong focus on oncology, critical care, and near-term commercialization of biosimilars and specialty generics.[2][4][5][6][7][8][10]